Why the study?
Thyrotoxic periodic paralysis with hypokalaemia is rare, and while high-dose non-selective beta-blockers resolve symptoms, delayed administration often leads to overcorrection and hyperkalaemia.
Does low-dose oral propranolol prevent overcorrection of potassium in a patient with thyrotoxic periodic paralysis?
Does low-dose oral propranolol prevent overcorrection of potassium in a patient with thyrotoxic periodic paralysis?
Low-dose oral propranolol administered in the emergency department may successfully prevent overcorrection of potassium in patients with thyrotoxic periodic paralysis.
Answers are grounded in this paper and cite their sources.
May prevent potassium overcorrection in thyrotoxic periodic paralysis when added to supplementation; hypothesis-generating from one case and needs prospective confirmation.
WHAT IS KNOWN AND OBJECTIVE: Thyrotoxic periodic paralysis (TPP) with hypokalaemia is a rare acute phenomenon. Reports of the use of high-dose non-selective β-blockers describe symptom resolution, but often administration does not occur promptly enough in the treatment course and patients may experience overcorrection and hyperkalaemia. CASE DESCRIPTION: A 37-year-old Hispanic male developed TPP. Patient was successfully treated with low-dose oral propranolol and potassium supplementation with no overcorrection. WHAT IS NEW AND CONCLUSION: Delay in the administration of non-selective β-blockers may lead to overcorrection of potassium with exogenous supplementation. Low-dose propranolol administered in the Emergency Department was successful in preventing overcorrection of potassium.
No takes yet. Share an insight, caveat, or question.
Wassner et al. (2020) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: